Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1993) 1993
Newsletter (82) 82
Book Chapter (34) 34
Newspaper Article (9) 9
Dissertation (1) 1
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1553) 1553
science & technology (1195) 1195
life sciences & biomedicine (1179) 1179
mucormycosis (1169) 1169
male (987) 987
mucormycosis - drug therapy (929) 929
antifungal agents - therapeutic use (728) 728
female (669) 669
middle aged (620) 620
amphotericin b - therapeutic use (574) 574
infectious diseases (550) 550
adult (534) 534
mucormycosis - diagnosis (521) 521
mucormycosis - microbiology (402) 402
biological and medical sciences (386) 386
medical sciences (378) 378
aged (343) 343
mucormycosis - complications (325) 325
mycoses (322) 322
microbiology (282) 282
health aspects (275) 275
amphotericin b (267) 267
care and treatment (264) 264
mucormycosis - pathology (264) 264
mucormycosis - etiology (254) 254
antifungal agents (253) 253
immunocompromised host (240) 240
fungal infections (222) 222
mycology (218) 218
risk factors (218) 218
mucormycosis - surgery (215) 215
treatment outcome (215) 215
zygomycosis (215) 215
human mycoses (209) 209
fatal outcome (207) 207
mortality (204) 204
adolescent (198) 198
antifungal agents - administration & dosage (187) 187
surgery (183) 183
aspergillosis (176) 176
fungi (176) 176
diagnosis (173) 173
child (172) 172
transplantation (171) 171
diabetes (166) 166
tomography, x-ray computed (165) 165
amphotericin b - administration & dosage (164) 164
triazoles - therapeutic use (163) 163
mucormycosis - therapy (161) 161
abridged index medicus (155) 155
immunology (149) 149
dermatology (148) 148
infections (148) 148
posaconazole (145) 145
debridement (139) 139
patients (138) 138
rhizopus - isolation & purification (138) 138
research (135) 135
hematology (133) 133
lung diseases, fungal - drug therapy (130) 130
combined modality therapy (123) 123
tropical mycoses (122) 122
animals (121) 121
phycomycoses (121) 121
retrospective studies (115) 115
rhizopus (115) 115
antiparasitic agents (114) 114
mucorales - isolation & purification (114) 114
medicine & public health (111) 111
case report (109) 109
pharmacology & pharmacy (109) 109
diabetes mellitus (106) 106
general & internal medicine (106) 106
pediatrics (106) 106
infection (104) 104
aspergillosis - drug therapy (102) 102
case studies (102) 102
drug therapy, combination (102) 102
pharmacology. drug treatments (102) 102
drug therapy (101) 101
mucormycosis - epidemiology (101) 101
young adult (100) 100
oncology (96) 96
diagnosis, differential (95) 95
biopsy (92) 92
mucorales (88) 88
medical research (84) 84
child, preschool (83) 83
leukemia (83) 83
medicine, general & internal (82) 82
magnetic resonance imaging (81) 81
diabetes complications (80) 80
mycoses - drug therapy (80) 80
voriconazole (78) 78
antibiotics. antiinfectious agents. antiparasitic agents (77) 77
epidemiology (76) 76
internal medicine (75) 75
medicine, experimental (75) 75
lung diseases, fungal - diagnosis (74) 74
mucormycosis - immunology (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1988) 1988
Spanish (52) 52
German (51) 51
French (46) 46
Japanese (20) 20
Portuguese (7) 7
Chinese (6) 6
Russian (5) 5
Dutch (3) 3
Italian (3) 3
Czech (2) 2
Danish (2) 2
Hungarian (2) 2
Korean (2) 2
Norwegian (2) 2
Polish (2) 2
Turkish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
by Spellberg, Brad and Ibrahim, Ashraf S and Chin-Hong, Peter V and Kontoyiannis, Dimitrios P and Morris, Michele I and Perfect, John R and Fredricks, David and Brass, Eric P
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 3/2012, Volume 67, Issue 3, pp. 715 - 722
Antifungal | Fungal infections | Combination therapy | Mould infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Mucormycosis - mortality | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Benzoates - administration & dosage | Drug Therapy, Combination - methods | Animals | Survival Analysis | Amphotericin B - administration & dosage | Adult | Female | Aged | Iron Chelating Agents - administration & dosage | Mice | Mucormycosis - drug therapy | Antifungal Agents - administration & dosage | Placebos - administration & dosage | Clinical trials | Drug therapy | Pathogenesis | Rodents | Mortality | Index Medicus | mould infections | antifungal | combination therapy | Original Research | fungal infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
by Bellmann, Romuald and Smuszkiewicz, Piotr
Infection, ISSN 0300-8126, 12/2017, Volume 45, Issue 6, pp. 737 - 779
Extracorporeal membrane oxygenation | Critically ill | General Practice / Family Medicine | Internal Medicine | Liposomal amphotericin B | Medicine & Public Health | Amphotericin B lipid formulations | Polyenes | Voriconazole | Caspofungin | Echinocandins | Infectious Diseases | Renal replacement therapy | Itraconazole | Life Sciences & Biomedicine | Science & Technology | Tissue Distribution | Drug Interactions | Drug Therapy, Combination - utilization | Antifungal Agents - pharmacokinetics | Humans | Mycoses - drug therapy | Complications and side effects | Dosage and administration | Amphotericin B | Drug therapy | Cytochrome | Drugs | Brain | Therapy | Fungicides | Liver | Tissues | Heterocyclic compounds | Bioaccumulation | Spleen | Urine | Kidneys | Fluconazole | Isoenzymes | Cytochrome P450 | Cryptococcosis | Substrate inhibition | Pharmacology | Metabolism | Micafungin | Substrates | Mucormycosis | Azoles | Lungs | Aspergillosis | Myocardium | Flucytosine | Pharmacokinetics | Posaconazole | Kidney transplantation | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Invasive Mycoses: Strategies for Effective Management
by Kontoyiannis, Dimitrios P., MD, ScD
The American journal of medicine, ISSN 0002-9343, 2012, Volume 125, Issue 1, pp. S25 - S38
Internal Medicine | Therapeutic drug monitoring | Echinocandins | Mucormycosis | Amphotericin B | Triazoles | Hepatotoxicity | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Mycoses - microbiology | Male | Alanine Transaminase - blood | Antineoplastic Agents - administration & dosage | Echinocandins - administration & dosage | Liver - drug effects | Antineoplastic Agents - adverse effects | Antifungal Agents - pharmacokinetics | Mycoses - metabolism | Adult | Female | Mucormycosis - surgery | Mucormycosis - drug therapy | Alkaline Phosphatase - blood | Myelodysplastic Syndromes - drug therapy | Aspergillosis - drug therapy | Flucytosine - administration & dosage | Liver - metabolism | Risk Factors | Leukemia - drug therapy | Mycoses - surgery | Pneumonia - microbiology | Biomarkers - blood | Bilirubin - blood | Flucytosine - adverse effects | Echinocandins - adverse effects | Pneumonia - drug therapy | Aspartate Aminotransferases - blood | Liver Function Tests - standards | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Immunocompromised Host | Drug Monitoring | Antifungal Agents - administration & dosage | Care and treatment | Mycoses | Diagnosis | Research | Health aspects | Risk factors | Drug therapy | Epidemiology | Fungal infections | Index Medicus | Abridged Index Medicus | Drugs | flucytosine | Pharmacodynamics | Risk groups | Mortality | Antifungal agents | Molds | triazoles | Radicals | Infection | Lipophilic | hepatotoxicity | Voriconazole | Pharmacokinetics | Posaconazole | Itraconazole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Changes in the epidemiological landscape of invasive mould infections and disease
by Lass-Flörl, Cornelia and Cuenca-Estrella, Manuel
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 03/2017, Volume 72, Issue suppl_1, pp. i5 - i11
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Mucormycosis - epidemiology | Fusariosis - epidemiology | Humans | Scedosporium - drug effects | Drug Resistance, Fungal - physiology | Mucorales - drug effects | Fusarium - drug effects | Aspergillosis - epidemiology | Antifungal Agents - therapeutic use | Invasive Fungal Infections - drug therapy | Mucormycosis - microbiology | Aspergillosis - microbiology | Fusariosis - drug therapy | Immunocompromised Host | Mucormycosis - drug therapy | Invasive Fungal Infections - microbiology | Aspergillosis - drug therapy | Fusariosis - microbiology | Invasive Fungal Infections - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights